Mon, September 18, 2017
Fri, September 15, 2017
Thu, September 14, 2017

Kennen MacKay Initiated (BMRN) at Hold and Held Target at $93 on, Sep 15th, 2017

Kennen MacKay of RBC Capital, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $93 on, Sep 15th, 2017.

Kennen has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $89 on, Thursday, July 27th, 2017


These are the ratings of the 2 analyists that currently disagree with Kennen


  • Christopher Raymond of "Piper Sandler" Initiated at Buy on, Thursday, September 14th, 2017
  • Josh Schimmer of "Evercore ISI Group" Initiated at Buy on, Thursday, August 17th, 2017